| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |